Phospholipid–Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel

References

• Aguiar J, Carpena P, Molina-Bolívar JA, Ruiz CC. (2003). On the determination of the critical micelle concentration by the pyrene 1:3 ratio method. J Colloid Interface Sci 258:116–122.
   Web of Science ®Google Scholar
• Alkan-Onyuksel H, Ramakrishnan S, Chai HB, Pezzuto JM. (1994). A mixed micellar formulation suitable for the parenteral administration of Taxol. Pharm Res 11:206–212.
   PubMed Web of Science ®Google Scholar
• Bakshi MS, Singh J, Kaur G. (2005). Antagonistic mixing behavior of cationic gemini surfactants and triblock polymers in mixed micelles. J Colloid Interface Sci 285:403–412.
   PubMed Web of Science ®Google Scholar
• Cevc G. (2004). Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Deliv Rev 56:675–711.
   PubMed Web of Science ®Google Scholar
• Cevc G, Gebauer D. (2003). Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J 84:1010–1024.
   PubMed Web of Science ®Google Scholar
• Dabholkar RD, Sawant RM, Mongayt DA, Devarajan PV, Torchilin VP. (2006). Polyethylene glycol–phosphatidylethanolamine conjugate (PEG–PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux. Int J Pharm 315:148–157.
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. (2009). Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 133:11–17.
   PubMed Web of Science ®Google Scholar
• Fadda M, Baroli BM, Maccioni AM, Sinico C, Valent D, Alhaiqu F. (1998). Phospholipid–detergent systems: effects of polysorbates on the release of liposomal caffeine. II Farmaco 53:650–654.
   Google Scholar
• Fjällskog ML, Frii L, Bergh J. (1993). Is Cremophor EL, solvent for paclitaxel, cytotoxic? Lancet 342:873.
   PubMed Web of Science ®Google Scholar
• Gabizon AA. (1995). Liposome circulation time and tumor targeting: implications for cancer chemotherapy. Adv Drug Deliv Rev 16:285–294.
   Web of Science ®Google Scholar
• Gao ZG, Fain HD, Rapoport N. (2005). Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J Control Release 102:203–222.
   PubMed Web of Science ®Google Scholar
• Gao ZG, Lukyanov AN, Singhal A, TorchilinVP. (2002). Diacyl lipid polymer micelles as nanocarriers for poorly soluble anticancer drugs. Nano Letters 2:979–982.
   Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, Leroux JC. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109:169–188.
   PubMed Web of Science ®Google Scholar
• Gelderblom H, Verweij J, Nooter K, Sparreboom A. (2001). Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37:1590–1598.
   PubMed Web of Science ®Google Scholar
• Haque ME, Das AR, Moulik SP. (1999). Mixed micelles of sodium deoxycholate and polyoxyethylene sorbitan monooleate (Tween 80). J Colloid Interface Sci 217:1–7.
   PubMed Web of Science ®Google Scholar
• Huh KM, Lee SC, Cho YW, Lee J, Jeong JH, Park K. (2005). Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 101:59–68.
   PubMed Web of Science ®Google Scholar
• Khatua D, Gupta A, Dey J. (2006). Characterization of micelle formation of dodecyldimethyl-N-2-phenoxyethylammonium bromide in aqueous solution. J Colloid Interface Sci 298:451–456.
   PubMed Web of Science ®Google Scholar
• Kollipara S, Bende G, Movva S, Saha R. (2010). Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel. Drug Dev Ind Pharm 36:1377–1387.
   PubMed Web of Science ®Google Scholar
• Koo OM, Rubinstein I, Onyuksel H. (2005). Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. Nanomedicine 1:77–84.
   PubMed Web of Science ®Google Scholar
• Lee CS, Kim C, Chan Kwon I, Chung H, Young Jeong S. (2003). Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. J Control Release 89:437–446.
   PubMed Web of Science ®Google Scholar
• Leng J, Egelhaaf SU, Cates ME. (2003). Kinetics of the micelle-to-vesicle transition: aqueous lecithin–bile salt mixtures. Biophys J 85:1624–1646.
   PubMed Web of Science ®Google Scholar
• Li L, Tan YB. (2008). Preparation and properties of mixed micelles made of Pluronic polymer and PEG–PE. J Colloid Interface Sci 317:326–331.
   PubMed Web of Science ®Google Scholar
• Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA. (1983). Role of surface-active phospholipids in gastric cytoprotection. Science 219:1327–1329.
   PubMed Web of Science ®Google Scholar
• Liggins RT, Burt HM. (2002). Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 54:191–202.
   PubMed Web of Science ®Google Scholar
• Lukyanov AN, Torchilin VP. (2004). Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev 56:1273–1289.
   PubMed Web of Science ®Google Scholar
• Lundberg BB, Risovic V, Ramaswamy M, Wasan KM. (2003). A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Release 86:93–100.
   PubMed Web of Science ®Google Scholar
• Maeda H, Sawa T, Konno T. (2001). Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release 74:47–61.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. (2000). Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284.
   PubMed Web of Science ®Google Scholar
• Martin GP, Marriott C. (1981). Membrane damage by bile salts: the protective function of phospholipids. J Pharm Pharmacol 33:754–759.
   PubMed Web of Science ®Google Scholar
• Miyahara M, Kawasaki H, Garamus VM, Nemoto N, Kakehashi R, Tanaka S, Annaka M, Maeda H. (2004). Micelle–vesicle transition of oleyldimethylamine oxide in water. Colloids Surf B Biointerfaces 38:131–138.
   PubMed Web of Science ®Google Scholar
• Nishiyama N, Kataoka K. (2001). Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core. J Control Release 74:83–94.
   PubMed Web of Science ®Google Scholar
• Ollivon M, Lesieur S, Grabielle-Madelmont C, Paternostre M. (2000). Vesicle reconstitution from lipid–detergent mixed micelles. Biochim Biophys Acta 1508:34–50.
   PubMed Web of Science ®Google Scholar
• Rijcken CJ, Snel CJ, Schiffelers RM, van Nostrum CF, Hennink WE. (2007). Hydrolysable core-crosslinked thermosensitive polymeric micelles: synthesis, characterisation and in vivo studies. Biomaterials 28:5581–5593.
   PubMed Web of Science ®Google Scholar
• Sautou-Miranda V, Brigas F, Vanheerswynghels S, Chopineau J. (1999). Compatibility of paclitaxel in 5% glucose solution with ECOFLAC low-density polyethylene containers-stability under different storage conditions. Int J Pharm 178:77–82.
   PubMed Web of Science ®Google Scholar
• Sezgin Z, Yüksel N, Baykara T. (2006). Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm 64:261–268.
   PubMed Web of Science ®Google Scholar
• Simões SI, Marques CM, Cruz ME, Cevc G, Martins MB. (2004). The effect of cholate on solubilisation and permeability of simple and protein-loaded phosphatidylcholine/sodium cholate mixed aggregates designed to mediate transdermal delivery of macromolecules. Eur J Pharm Biopharm 58:509–519.
   PubMed Web of Science ®Google Scholar
• Simões SI, Tapadas JM, Marques CM, Cruz ME, Martins MB, Cevc G. (2005). Permeabilisation and solubilisation of soybean phosphatidylcholine bilayer vesicles, as membrane models, by polysorbate, Tween 80. Eur J Pharm Sci 26:307–317.
   PubMed Web of Science ®Google Scholar
• Singla AK, Garg A, Aggarwal D. (2002). Paclitaxel and its formulations. Int J Pharm 235:179–192.
   PubMed Web of Science ®Google Scholar
• Stuart MC, Boekema EJ. (2007). Two distinct mechanisms of vesicle-to-micelle and micelle-to-vesicle transition are mediated by the packing parameter of phospholipid–detergent systems. Biochim Biophys Acta 1768:2681–2689.
   PubMed Web of Science ®Google Scholar
• Szebeni J, Muggia FM, Alving CR. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst 90:300–306.
   PubMed Web of Science ®Google Scholar
• Sznitowska M, Klunder M, Placzek M. (2008). Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin. Chem Pharm Bull 56:70–74.
   PubMed Web of Science ®Google Scholar
• van Tellingen O, Beijnen JH, Verweij J, Scherrenburg EJ, Nooijen WJ, Sparreboom A. (1999). Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice. Clin Cancer Res 5:2918–2924.
   PubMed Web of Science ®Google Scholar
• van Zuylen L, Verweij J, Sparreboom A. (2001). Role of formulation vehicles in taxane pharmacology. Invest New Drugs 19:125–141.
   PubMed Web of Science ®Google Scholar
• Wang J, Mongayt D, Torchilin VP. (2005). Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)–lipid conjugate and positively charged lipids. J Drug Target 13:73–80.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang YJ, Wang DQ. (2008). Dual effects of Tween 80 on protein stability. Int J Pharm 347:31–38.
   PubMed Web of Science ®Google Scholar
• Wu L, Tang C, Yin C. (2010). Folate-mediated solid–liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm 36:439–448.
   PubMed Web of Science ®Google Scholar
• Yang TF, Chen CN, Chen MC, Lai CH, Liang HF, Sung HW. (2007). Shell-crosslinked Pluronic L121 micelles as a drug delivery vehicle. Biomaterials 28:725–734.
   PubMed Web of Science ®Google Scholar
• Yi Y, Yoon HJ, Kim BO, Shim M, Kim SO, Hwang SJ, Seo MH. (2007). A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity and pharmacokinetics. J Control Release 117:59–67.
   PubMed Web of Science ®Google Scholar
• Yin H, Lei S, Zhu S, Huang J, Ye J. (2006). Micelle-to-vesicle transition induced by organic additives in cationic surfactant systems. Chemistry 12:2825–2835.
   PubMed Web of Science ®Google Scholar
• Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, Jain RK. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–3756.
   PubMed Web of Science ®Google Scholar
• Zhang C, Qu G, Sun Y, Wu X, Yao Z, Guo Q, Ding Q, Yuan S, Shen Z, Ping Q, Zhou H. (2008). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials 29:1233–1241.
   PubMed Web of Science ®Google Scholar
• Zhang JA, Anyarambhatla G, Ma L, Ugwu S, Xuan T, Sardone T, Ahmad I. (2005). Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biopharm 59:177–187.
   PubMed Web of Science ®Google Scholar